AI play BioXcel raises $60M IPO

Artificial intelligence company BioXcel Therapeutics Inc. (NASDAQ:BTAI) raised $60 million on March 8 through the sale of 5.5 million shares at $11 in an upsized IPO underwritten by Barclays, UBS, BMO and Canaccord Genuity. The price valued the company at $172.1 million. BioXcel priced the offering at the bottom of its proposed $11-$13 range; it said earlier in the week it hoped to sell 5 million shares...